AADI BIOSCIENCE INC's ticker is and the CUSIP is 00032Q104. A total of 69 filers reported holding AADI BIOSCIENCE INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $201,000 | – | 11,513 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 26,666 | $182,395 | 24.91% |
| Alerce Investment Management, L.P. | 1,630,830 | $11,154,877 | 14.51% |
| ACUTA CAPITAL PARTNERS, LLC | 1,849,402 | $12,649,910 | 8.57% |
| Decheng Capital Management III (Cayman), LLC | 526,329 | $3,600,090 | 1.13% |
| Knott David M Jr | 261,000 | $1,785 | 0.71% |
| Ghost Tree Capital, LLC | 250,000 | $1,710,000 | 0.56% |
| Affinity Asset Advisors, LLC | 187,675 | $1,283,697 | 0.45% |
| Vivo Capital, LLC | 509,572 | $6,456,277 | 0.45% |
| Avoro Capital Advisors LLC | 2,849,402 | $19,489,910 | 0.26% |
| Lion Point Capital, LP | 82,423 | $563,773 | 0.26% |